Brief: Grifols Expands Diagnostic Production Capacity In US With New Plant In San Diego
16/10/2025 13:13
Oct 16 (Reuters) - Grifols SA GRLS.MC: EXPANDS ITS DIAGNOSTIC PRODUCTION CAPACITY IN US WITH NEW PLANT IN SAN DIEGO BEGINS MANUFACTURING DG GEL CARDS AND RED BLOOD CELL REAGENTS Further company coverage: GRLS.MC (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Grifols SA
See all newsSpanish stocks - Factors to watch on June 24
Brief: Grifols Approves Reduction Of Up To 10% Of Its Share Capital
Brief: Grifols Launches Fibrinogen Concentrate For Acute Bleeding Episodes In The U.S.
Brief: Grifols' Egypt Unit Adds €180 Mln Of Additional Investment In Project
Spanish stocks - Factors to watch on June 12